CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. CD24 Protein-VLP, Cynomolgus, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 3.8 kDa and the accession number is XP_015304503.1.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
100 μg | 約5 days | ¥ 424,500 |
500 μg | 約5 days | ¥ 1,712,000 |
1 mg | 約5 days | ¥ 2,853,000 |
説明 | CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. CD24 Protein-VLP, Cynomolgus, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 3.8 kDa and the accession number is XP_015304503.1. |
Species | Cynomolgus |
Expression Host | HEK293 Cells |
Accession Number | XP_015304503.1 |
別名 | MGC75043, CD 24, FLJ43543, FLJ22950, CD24 molecule, CD24A |
Construction | Ser26-Gly57 |
Protein Purity | > 90% as determined by HPLC |
分子量 | 3.8 kDa (predicted) |
Endotoxin | < 1 EU/μg by the LAL method. |
Formulation | Supplied as 0.22 μm filtered solution in PBS (pH 7.4).Notice: If you need it for immunization, Do Not use any adjuvant. |
Stability & Storage |
It is recommended to store the product under sterile conditions at -70℃ or lower. Samples are stable for up to 12 months at -80℃. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping |
In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
Research Background | CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. |
bottom
Please read the User Guide of Recombinant Proteins for more specific information.
CD24 Protein-VLP, Cynomolgus, Recombinant CD24 FLJ 22950 MGC 75043 MGC75043 CD-24 CD 24 FLJ43543 FLJ22950 FLJ 43543 CD24 molecule CD24A FLJ-22950 MGC-75043 FLJ-43543 recombinant recombinant-proteins proteins protein